pancreatic cancer

Showing NaN - NaN of 52

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Rochester (Bio-specimen Collection: Blood, Bio-specimen

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Bio-specimen Collection: Blood
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Nov 21, 2023

Solid Tumor, Adult, Solid Tumor, Pancreatic Cancer Trial in United States (A2B530, xT-Onco with HLA-LOH Assay)

Not yet recruiting
  • Solid Tumor, Adult
  • +15 more
  • A2B530
  • xT-Onco with HLA-LOH Assay
  • Duarte, California
  • +6 more
Feb 10, 2023

Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +4 more
  • GRT-C903
  • +3 more
  • Phoenix, Arizona
  • +13 more
Jan 30, 2023

Validation for Early Cancer Detection and Minimal Residual

Recruiting
  • Brain Cancer
  • +19 more
    • Duarte, California
    • +6 more
    Nov 10, 2022

    Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

    Available
    • Non Small Cell Lung Cancer
    • +6 more
    • Goodyear, Arizona
    • +67 more
    Aug 17, 2022

    Pancreatic Adenosquamous Carcinoma, Resectable Pancreatic Adenocarcinoma, Pancreatic Cancer Trial in United States (drug,

    Recruiting
    • Pancreatic Adenosquamous Carcinoma
    • +2 more
    • Mobile, Alabama
    • +182 more
    Aug 1, 2022

    Advanced Cancer, Gastric Cancer, Breast Cancer Trial in United States (Minnelide™Capsules)

    Recruiting
    • Advanced Cancer
    • +9 more
    • Birmingham, Alabama
    • +6 more
    Apr 4, 2022

    Pancreatic Cancer Trial in Netherlands, United States (CCX872-B)

    Completed
    • Pancreatic Cancer
    • Saint Louis, Missouri
    • +5 more
    Mar 14, 2022

    Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Trial in Rochester (SX-682, Nivolumab Injectable Product)

    Recruiting
    • Pancreatic Ductal Adenocarcinoma
    • Pancreatic Cancer
    • SX-682
    • Nivolumab Injectable Product
    • Rochester, New York
      University of Rochester
    Dec 14, 2021

    Collecting Medical Information and Tissue Samples From

    Recruiting
    • Islet Cell Tumor
    • +2 more
    • medical chart review
    • +2 more
    • Rochester, Minnesota
      Mayo Clinic Cancer Center
    Sep 28, 2021

    Metastatic Pancreatic Cancer, Pancreatic Cancer Trial in Worldwide (IMMU-107, , Gemcitabine)

    Terminated
    • Metastatic Pancreatic Cancer
    • Pancreatic Cancer
    • Gilbert, Arizona
    • +64 more
    Aug 12, 2021

    Liver Cancer, Anxiety Disorder, Depression Trial in United States (Early palliative care)

    Completed
    • Liver Cancer
    • +9 more
    • Early palliative care
    • La Jolla, California
    • +22 more
    Jul 22, 2021

    Advanced Solid Tumors, Solid Tumors, Pancreatic Cancer Trial in Rochester, Saint Louis (Defactinib, Pembrolizumab, Gemcitabine)

    Completed
    • Advanced Solid Tumors
    • +2 more
    • Defactinib
    • +2 more
    • Rochester, Minnesota
    • +1 more
    Jul 18, 2021

    Pancreatic Cancer Trial in Worldwide (Demcizumab, Abraxane®, gemcitabine)

    Completed
    • Pancreatic Cancer
    • Gilbert, Arizona
    • +41 more
    Sep 7, 2020

    Pancreatic Cancer Trial in United States (biological, drug, radiation)

    Completed
    • Pancreatic Cancer
    • HyperAcute-Pancreas Immunotherapy
    • +2 more
    • Birmingham, Alabama
    • +74 more
    May 26, 2020

    Pancreatic Cancer Trial in Worldwide (erlotinib HCl, gemcitabine HCl)

    Completed
    • Pancreatic Cancer
    • erlotinib hydrochloride
    • gemcitabine hydrochloride
    • Tucson, Arizona
    • +172 more
    Mar 31, 2020

    Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Israel, United States (Rucaparib)

    Completed
    • Pancreatic Cancer
    • Pancreatic Ductal Adenocarcinoma
    • Los Angeles, California
    • +7 more
    Jan 21, 2020

    Pancreatic Cancer Trial in Worldwide (Ruxolitinib, Placebo, Capecitabine)

    Terminated
    • Pancreatic Cancer
    • Avondale, Arizona
    • +229 more
    Mar 14, 2019

    Pancreatic Cancer Trial in Jacksonville, Rochester (LY2090314, FOLFOX, Gemcitabine)

    Terminated
    • Pancreatic Cancer
    • Jacksonville, Florida
    • +1 more
    Jan 11, 2019

    Breast Cancer, Lung Cancer, Pancreatic Cancer Trial in United States (INO-1400, INO-9012, INO-1401)

    Completed
    • Breast Cancer
    • +8 more
    • INO-1400
    • +2 more
    • Detroit, Michigan
    • +5 more
    Nov 15, 2018

    Pancreatic Cancer, Non-Small-Cell Lung Cancer Trial in Rochester (Dignity Therapy)

    Completed
    • Pancreatic Cancer
    • Non-Small-Cell Lung Cancer
    • Dignity Therapy
    • Rochester, Minnesota
      Mayo Clinic
    Mar 19, 2018

    Pancreatic Cancer Trial in Worldwide (Ruxolitinib, Placebo, Capecitabine)

    Terminated
    • Pancreatic Cancer
    • Huntsville, Alabama
    • +94 more
    Jan 15, 2018